[1] MCKINNON K M，CLARK T M，HOFFMAN G

S. Limitations of therapy and a guarded prognosis in

an American cohort of Takayasu arteritis patients[J].

Arthritis Rheum，2007，56（3）：1000-1009.

[2] YANG L R，ZHANG H M，JIANG X J，et al. Clinical

manifestations and longterm outcome for patients with

Takayasu arteritis in China[J]. Scand J Rheumatol，

2014，41（12）：2439-2446.

[3] JAIN S，KUMARI S，GANGULY N K，et al. Current

status of Takayasu arteritis in India[J/OL]. Int J Cardiol，

1996，54（Suppl）：S111-116[2020-03-01]. https：//doi.

org/10.1016/s0167-5273（96）88780-8.

[4] TOMELLERI A，CAMPOCHIARO C，SARTORELLI

S，et al. Gender differences in clinical presentation and

vascular pattern in patients with Takayasu arteritis[J].

Scand J Rheumatol，2019，48（6）：482-490.

[5] AREND W P，MICHEL B A，BLOCH D A，et al. The

American College of Rheumatology 1990 criteria for

the classification of Takayasu arteritis[J]. Arthritis

Rheuma，1990，33（8）：1129-1134.

[6] CUI X，QIN F，SONG L，et al. Novel biomarkers for

the precisive diagnosis and activity classification of

Takayasu arteritis[J/OL]. Circ Genom Precis Med，2019，

12（1）：e002080[2020-03-01]. https：//doi.org/10.1016/

j.lpm.2017.03.022.

[7] PEDREIRA A L S，SANTIAGO M B. Association

between Takayasu arteritis and latent or active

Mycobacterium tuberculosis infection：a systematic

review[J]. Clin Rheumatol，2020，39（4）：1019-1026.

[8] GIORDANA P，BAQUÉ-JUSTON M C，JEANDEL

P Y，et al. Contrast-enhanced ultrasound of carotid

artery wall in Takayasu disease：first evidence of

application in diagnosis and monitoring of response to

treatment[J]. Circulation，2011，124（2）：245-247.

[9] LOTTSPEICH C，DECHANT C，KÖHLER A，et al.

Assessment of disease activity in Takayasu arteritis：

potential roleofcontrast-enhanced ultrasound[J].

Ultraschall Med，2019，40（5）：638-645.

[10] TOMBETTI E，MASON J C. Application of imaging

techniques for Takayasu arteritis[J/OL]. Presse Med，

2017，46（7/8 Pt 2）：e215-e223[2020-03-01].

https：//doi.org/10.1016/j.lpm.2017.03.022.

[11] CHRAPKO B E，CHRAPKO M，NOCU? A，et

al. Role of 18F-FDG PET/CT in the diagnosis of

inflammatory and infectious vascular disease[J]. Nucl

Med Rev Cent East Eur，2016，19（1）：28-36.

[12] MAEDA H，HANDA N，MATSUMOTO M，et al.

Carotid lesions detected by B-mode ultrasonography

in Takayasu's arteritis："macaroni sign" as an indicator

of the disease [J]. Ultrasound Med Biol，1991，17（7）：

695-701.

[13] WILLRUTH A M，DWINGER N，RITGEN

J，et al. Fetal aberrant right subclavian artery

（ARSA）：a potential new soft marker in the

genetic scan?[J/OL]. Ultraschall Med，2012，33（7）：

E114-E118[2020-03-01]. https：//doi.org/10.1055/

s-0029-1245935.

[14] KESER G，AKSU K. What is new in management of

Takayasu arteritis?[J/OL]. Presse Med，2017，46（7/8

Pt 2）：e229-e235[2020-03-01]. https：//doi.org/10.

1016/j.lpm.2016.11.033.

[15] KWON O C，OH J S，PARK M C，et al. Statins

reduce relapse rate in Takayasu arteritis[J/OL]. Int J

Cardiol，2019，287：111-115[2020-03-01]. https：//doi.

org/10.1016/j.ijcard.2019.02.046.